Selectively Targeting STAT3 Using a Small Molecule Inhibitor Is a Potential Therapeutic Strategy for Pancreatic Cancer

On target effects of WB436B were examined by microscale thermophoresis, surface plasmon resonance, in vitro kinase assay, RNA sequencing, and selective cell growth inhibition assessment.